Status:

COMPLETED

Effect of Monitoring Devices on Healthcare Provider Performance During Neonatal Resuscitation

Lead Sponsor:

University of Alberta

Conditions:

Prematurity

Eligibility:

All Genders

Phase:

NA

Brief Summary

Babies born very early (at less than 32 weeks) usually need help to breath right at birth, also called neonatal resuscitation. Healthcare providers (HCPs) are specially trained to provide this help. H...

Detailed Description

The investigators aim to study 93 resuscitations of very preterm infants (23+0-31+6 weeks), in consecutive groups of 31. First, as a baseline, 31 infants will be resuscitated using the standard approa...

Eligibility Criteria

Inclusion

  • HCPs participating in resuscitations of very preterm infants (23+0-31+6 weeks) at the Royal Alexandra Hospital Neonatal Intensive Care Unit (NICU), a Level III NICU will be included.
  • Multiple gestations will be analyzed individually as separate resuscitations. HCPs will include different levels of experience and different disciplines (registered nurses, advance practice nurses, respiratory therapists, neonatal nurse practitioners, pediatric residents, neonatal fellows, clinical associates, and neonatal consultants).
  • All HCPs who participate in the resuscitation, regardless of role, will be eligible for completion of NASA-TLX surveys.
  • Participants who act as team leader will be eligible to be fitted with eye-tracking glasses to record their visual attention and Empatica E4 wristbands to measure physiological stress measurements.
  • For resuscitated infants, hospital outcomes will be included with parental consent.

Exclusion

  • Teams involved in the resuscitation of infants born with congenital malformations, or involved in the care of infants for whom active resuscitation is not planned (i.e., comfort care only for periviable gestations) will be excluded.
  • Teams who do not consent to participate will also be excluded.

Key Trial Info

Start Date :

October 5 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 18 2021

Estimated Enrollment :

51 Patients enrolled

Trial Details

Trial ID

NCT04521725

Start Date

October 5 2020

End Date

November 18 2021

Last Update

January 13 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Royal Alexandra Hospital

Edmonton, Alberta, Canada